Author(s)

Simant Ankit¹, Tongxiang Zeng^1*, Yangxin Chen¹, Hari Narayan Gupta², Kunal Shah¹, Xianwang Wang^1,3*

¹Department of Dermatology & Venereology, Jingzhou Central Hospital & The Second Clinical School of Medicine, Yangtze University, Jingzhou, China.
²Department of Dermatology & Venereology, Tribhuvan University, Kathmandu, Nepal.
³Laboratory of Oncology, Center for Molecular Medicine, School of Medicine, Yangtze University, Jingzhou, China.

Post herpetic neuralgia (PHN) is a chronic neuropathic pain syndrome in the area of the herpes zoster (HZ) rash, persisting after the cutaneous lesions have subsided. Despite numerous treatment advances, many patients remain refractory to the current therapies and continue to have pain, physical, economical and psychological distress. In this review, we will focus on the current treatment and prevention of PHN.

Post Herpetic Neuralgia, Current Treatment, Prevention

Ankit, S. , Zeng, T. , Chen, Y. , Gupta, H. , Shah, K. and Wang, X. (2018) The Current Treatment and Prevention of Post Herpetic Neuralgia. Yangtze Medicine, 2, 28-38. doi: 10.4236/ym.2018.21003.